Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 17:8:563525.
doi: 10.3389/fpubh.2020.563525. eCollection 2020.

Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea

Sora Lee  1
Affiliations

Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea

Sora Lee. Front Public Health. .

Abstract

Responsive private sector engagement in developing test kits for coronavirus disease (COVID-19) in South Korea offers a valuable case study in public-private partnership and infectious disease governance. Korean biotech firms promptly developed diagnostic test kits, and the nation achieved capacity to test more than 20,000 people daily. This was a direct result of the continuous application of lessons learned from the Middle Eastern respiratory syndrome outbreak in 2015. South Korea had been strengthening the private sectors' infectious disease governance and response capacity, creating various new constructive pathways toward public-private partnership. Regulatory amendments were made to better liaise with the private sector. Government-led investment had increased in the research and development of testing technologies over the past 5 years. Furthermore, the Korean government had introduced fast-tracking approval, allowing open competition for more than 20 domestic biotech companies to develop test kits. An overview of test kit governance informs us of the importance of public-private partnership for pandemic threats.

Keywords: COVID-19; South Korea; biotech industry; governance; infectious disease; private sector; test kit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Timeline of COVID-19 test kit development (–17).
See this image and copyright information in PMC

References

    1. KCDC Daily Briefing Report. KCDC (2020). Available online at: http://cdc.go.kr (accessed August 20).
    1. Oh M-D, Park WB, Park S-W, Choe PG, Bang JH, Song K-H, et al. . Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. (2018) 33:233–46. 10.3904/kjim.2018.031 - DOI - PMC - PubMed
    1. Tiang J, Ma D, Huang S, Han W. In Depth: Why South Korea is Winning the Coronavirus Battle Nikkei Asian Review. (2020). Available online at: https://asia.nikkei.com/Spotlight/Caixin/In-Depth-Why-South-Korea-is-win... (accessed August 20).
    1. Statutes of the Republic of Korea, Public Health and Medical Services Act (2014). Available online at:http://elaw.klri.re.kr/eng_service/lawPrint.do?hseq=26409 (accessed August 20). (in Korean).
    1. Kang KH. MERS outbreak and legal governance between central and local governments. Human Rights Just. (2015) 452:20–35. 10.1093/medlaw/fwx011 (in Korean). - DOI

Substances